Skip to main content

Table 3 Within-group changes in SF-36 domain and composite summary scores over time using per protocol analysisa

From: Improving health-related quality of life in women with breast, blood, and gynaecological Cancer with an eHealth-enabled 12-week lifestyle intervention: the women’s wellness after Cancer program randomised controlled trial

 

n

M (SD)

Cohen’s db

p1/p2

t0

t1

t2

d1

d2

Intervention group

 Physical functioning (PF)

119/115

47.9 (7.3)

49.5 (7.8)*

50.8 (7.6)*

0.20

0.24

 Role limitations/physical health (RP)

115/113

45.0 (11.3)

49.8 (9.8)**

48.9 (10.2)

0.45

-0.10

 Bodily pain (BP)

119/115

48.9 (8.9)

50.9 (9.1)*

50.3 (9.3)

0.22

-0.08

 General health (GH)

119/115

48.7 (8.1)

48.8 (8.8)

50.5 (8.8)

0.02

0.23

 Vitality (VT)

118/114

47.2 (8.7)

50.5 (8.8)**

51.0 (9.0)

0.37

0.08

 Social Functioning (SF)

119/115

46.6 (8.9)

49.8 (7.9)**

50.4 (8.1)

0.40

0.08

 Role limitations/emotional health (RE)

117/114

46.9 (11.3)

47.1 (11.0)

48.9 (10.2)

0.01

0.15

 Mental health (MH)

117/114

45.3 (8.5)

42.6 (8.6)**

50.8 (8.4)**

-0.34

1.26

 Physical component summary (PCS)

117/114

48.2 (8.1)

51.9 (8.6)**

50.2 (9.0)**

0.49

-0.27

 Mental component summary (MCS)

116/114

46.0 (9.8)

45.2 (9.8)

50.2 (9.1)**

-0.08

0.63

Control group

 Physical functioning (PF)

125/116

45.3 (8.9)

47.5 (8.1)**

47.7 (9.1)

0.32

0.04

 Role limitations/physical health (RP)

123/114

41.2 (11.7)

45.4 (11.8)**

44.8 (12.4)

0.34

-0.05

 Bodily pain (BP)

125/116

47.3 (8.9)

47.7 (9.6)

47.4 (10.0)

0.05

-0.03

 General health (GH)

125/116

47.8 (9.3)

46.8 (8.9)

47.0 (9.7)

-0.15

0.04

 Vitality (VT)

125/116

46.6 (9.4)

47.9 (9.4)

48.0 (10.0)

0.16

0.02

 Social Functioning (SF)

125/116

44.9 (10.4)

47.9 (10.0)**

48.1 (10.4)

0.33

0.02

 Role limitations/emotional health (RE)

121/114

44.9 (12.5)

49.6 (10.1)**

47.4 (12.1)

0.42

-0.19

 Mental health (MH)

125/116

46.1 (8.9)

41.9 (9.0)**

49.0 (10.1)**

-0.58

0.91

 Physical component summary (PCS)

125/116

45.3 (9.7)

47.6 (9.3)**

46.4 (10.4)

0.29

-0.18

 Mental component summary (MCS)

125/116

46.2 (10.9)

46.3 (9.8)

48.9 (11.4)**

0.01

0.27

  1. p1, Pair 1 (t0 vs. t1); p2, Pair 2 (t1 vs. t2); M mean value, SD standard deviation of the mean value; d1, effect size for pair 1; d2, effect size for pair 2; SF-36 Short Form 36
  2. aSplit sample paired sample t–tests
  3. bCohen’s d effect size accounting for the correlation between outcome variables over time
  4. *p < .05
  5. **p < .01
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us